Rick W. Eggert
Technik-/Wissenschafts-/F&E-Leiter bei Lundbeck, Inc.
Ursprung des Netzwerks ersten Grades von Rick W. Eggert
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Horizon Pharma, Inc.
 Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL.
10
| Extinct | Pharmaceuticals: Major | 10 |
Lundbeck, Inc.
 Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rick W. Eggert
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
InfaCare Pharmaceutical Corp.
 InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Biotechnology | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| DISCOVER FINANCIAL SERVICES | Finance/Rental/Leasing | Director/Board Member | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chairman | |
| University of Illinois | College/University | Masters Business Admin Undergraduate Degree | |
Euronext Paris SA
 Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France. | Investment Banks/Brokers | Director/Board Member | |
World Business Chicago
 World Business Chicago Miscellaneous Commercial ServicesCommercial Services World Business Chicago provides economic data and statistical assistance services. The company was founded in 1999 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
The Commercial Club of Chicago
 The Commercial Club of Chicago Miscellaneous Commercial ServicesCommercial Services The Commercial Club of Chicago works to shape the future of the region to make it a better place for everyone to live, work, and do business. The non-profit company is based in Chicago, IL. The company's civic committee has announced violence reduction goals and commitments to help address public safety. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
| Kaiser Electro-Optics, Inc. | Director of Finance/CFO | ||
| Kaiser Rollmet | Comptroller/Controller/Auditor | ||
Metronome Therapeutics, Inc.
 Metronome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metronome Therapeutics, Inc. manufactures and markets oncology drugs. It specializes in developing turnkey finished dosage forms of generic and drugs and has an affiliate assist producers of drugs in the diversification of their product portfolios. The company was founded by George Tidmarsh on January 13, 2006 and is headquartered in Delaware. | Pharmaceuticals: Major | Chief Executive Officer | |
Horizon Therapeutics USA, Inc.
 Horizon Therapeutics USA, Inc. Pharmaceuticals: MajorHealth Technology Horizon Therapeutics USA, Inc. develops prescription drugs for mild to moderate pain relief arthritis. The company is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal | |
| VisioMedtrics, Inc. | Director of Finance/CFO | ||
| Stanford University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin | |
SpePharm AG
 SpePharm AG Pharmaceuticals: MajorHealth Technology SpePharm AG acquires, registers, and markets medical value medicines for the hospital sector. Its brands include Dantrium IV, Dantrium, Dantamacrin, Lymphoseek and Mugard. The company was founded in 2012 and is headquartered in Luzern, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Centogene AG
 Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Medical/Nursing Services | Director/Board Member | |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Pharmaceuticals: MajorHealth Technology leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Chairman | |
Innovation Development Institute, Inc.
 Innovation Development Institute, Inc. Electronic Equipment/InstrumentsElectronic Technology Innovation Development Institute, Inc. operates as a community of healthcare innovators who aspire to heroic change. The company is headquartered in Chicago, IL. | Electronic Equipment/Instruments | Chairman Chairman | |
| TME PHARMA N.V. | Biotechnology | Chairman | |
AL-S Pharma AG
 AL-S Pharma AG Pharmaceuticals: MajorHealth Technology AL-S Pharma AG engages in the development and marketing of pharmaceutical products. The company was founded by Michael Salzmann on September 19, 2016 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Chairman | |
| ACER THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Paragon Biosciences LLC
 Paragon Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Paragon Biosciences LLC is a life science innovator that creates, invests in, and builds life science companies in biopharmaceuticals, cell and gene therapy, and synthetic biology utilizing artificial intelligence. Paragon Biosciences is based in Chicago, IL, and has subsidiaries in the United States. The private company's current portfolio includes Castle Creek Biosciences, Circ Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences Holdings, Qlarity Imaging, Skyline Biosciences, and a consistent flow of incubating companies created and supported by the Paragon Innovation Capital™ model. The company's mission is to solve complex human and societal challenges by creating and supporting focused, visionary companies that accelerate the development of novel therapies and life science breakthroughs. The company was founded by Jeffrey S. Aronin, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
| CENTOGENE N.V. | Miscellaneous Commercial Services | Director/Board Member | |
| Zeneca AGro Gmbh | Sales & Marketing | ||
TVM Life Science Management GmbH
 TVM Life Science Management GmbH Miscellaneous Commercial ServicesCommercial Services Part of TVM Capital GmbH, TVM Life Science Management GmbH provides management services. The company is based in Munich, Germany. The CEO of the German company is Stefan Fischer. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 35 |
| Deutschland | 12 |
| Schweiz | 3 |
| Irland | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 29 |
| Commercial Services | 8 |
| Consumer Services | 6 |
| Health Services | 3 |
| Finance | 3 |
Operativ
| Director/Board Member | 113 |
| Corporate Officer/Principal | 50 |
| Chairman | 38 |
| Independent Dir/Board Member | 34 |
| Chief Executive Officer | 22 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Timothy Walbert | 40 |
| Jeffrey Aronin | 35 |
| Jeff Bird | 30 |
| Hubert Birner | 27 |
| George Tidmarsh | 22 |
| Jeffrey Sherman | 21 |
| Eric Floyd | 18 |
| Sean Nolan | 18 |
| Robert J. de Vaere | 12 |
| Douglas R. Carlson | 9 |
| Paul M. Palz | 8 |
| Jeff Del Carmen | 7 |
| Andrew Serafin | 7 |
| Al Robichaud | 7 |
| Torsten Meldgaard Madsen | 5 |
- Börse
- Insiders
- Rick W. Eggert
- Unternehmensverbindungen